Postconfluent multilayered cell line cultures for selective screening of gemcitabine

This publication has 15 references indexed in Scilit:

• Comparison of the antitumor activity of gemcitabine and ara-C in a panel of human breast, colon, lung and pancreatic xenograft models
  Investigational New Drugs, 1996
• Phase II study of gemcitabine in previously platinum-treated ovarian cancer patients
  Anti-Cancer Drugs, 1995
• Schedule dependence of sensitivity to 2′,2′-difluorodeoxycytidine (gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumour cell lines and solid tumours
  Biochemical Pharmacology, 1994
• Cytotoxic effects of anticancer agents on subconfluent and multilayered postconfluent cultures
  European Journal Of Cancer, 1993
• 2′,2′-Difluoro-deoxycytidine (gemcitabine) incorporation into RNA and DNA of tumour cell lines
  Biochemical Pharmacology, 1993
• The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancer
  British Journal of Cancer, 1993
• Clinical and preclinical activity of 2′,2′- difluorodeoxycytidine (gemcitabine)
  Cancer Treatment Reviews, 1993
• Growth, morphology and chemosensitivity studies on postconfluent cells cultured in 'V'-bottomed microtiter plates
  British Journal of Cancer, 1992
• New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
  JNCI Journal of the National Cancer Institute, 1990
• 2',2'-Difluorodeoxycytidine Metabolism and Mechanism of Action In Human Leukemia Cells
  Nucleosides, Nucleotides and Nucleic Acids, 1989